Literature DB >> 31880113

[Study of the Role and Mechanism of Asprosin/Spartin Pathway in Cardiac Microvascular Endothelial Injury Induced by Diabete Mellitus].

Sha Chen1, Xiong Wang2, Chen-Ming Qiu2, Juan-Ni Hou2, Xiao-Yu Wei2, Chao-Xue Xiang2, Ming-Yang Tang2, Rui Zhang1,3, Hai-Feng Pei1.   

Abstract

OBJECTIVE: To detect the effects and mechanism of asprosin (Asp) and spartin on the injury of mice cardiac microvascular endothelial cells (CMECs) induced by high glucose.
METHODS: The cultured CMECs were divided into 2 groups, one group is normal group (5.5 mmol/L glucose in the medium) and another is HG group (30 mmol/L glucose in the medium). Real-time PCR (qRT-PCR) and Western blot were respectively used to detect the mRNA level of spastic paraplegia 20 (SPG20) and protein expression of spartin in CMECs. Upregulation or downregulation of the expression of spartin was achieved via transfection with adenovirus (Ad) or small interfering RNA (siRNA) respectively. CMECs with downregulation of spartin expression were firstly treated with anti-oxidant N-acetylcysteine (NAC) or Asp respectively for 48 h, and then were interfered with 30 mmol/L glucose for 24 h afterward. The apoptosis of cell was detected by flow cytometry. Nitric oxide (NO) production was detected by NO probe and ELISA kit. The intracellular reactive oxygen species (ROS) levels were tested by DHE staining and ELISA kit. Type 2 diabetic model mice were established and then divided into T2DM group and T2DM+Asp group. After the model mice were established successfully (random blood glucose was more than 16.7 mmol/L), Asp (1 μg/g) was intraperitoneally injected once a day. After 2 weeks, mice echocardiography was performed to test cardiac diastolic function. The integrity of the microvascular endothelium was observed by scanning electron microscopy.
RESULTS: Compared with the normal group, the mRNA level of SPG20 and protein expression of spartin in mice CMECs of HG group were significantly reduced (P < 0.05). Under the condition of high glucose, Ad transfection induced significant decrease of the intracellular ROS level and the apoptosis level of the CMECs (P < 0.05), while NO increased after Ad transfection. In contrast, siRNA intervention resulted in opposite effect. In addition, the antioxidant NAC partly reversed the above changes caused by downregulating spartin. Asp upregulated the level of SPG20 mRNA and spartin protein expression in CMECs, reduced ROS production, reduced apoptosis and increased NO production. However, intervention effects of Asp, such as decreasing of ROS production, inhibiting apoptosis of CMECs and increasing of NO production, were partly reversed in spartin downregulated cells. In vivo, we found that Asp can improve cardiac function and increase the integrity and smoothness of cardiac microvascular endothelium in type 2 diabetic mice.
CONCLUSION: Asp can inhibit oxidative stress in mice CMECs through upregulating spartin signaling pathway, thereby alleviating the damage of microvascular endothelium in diabetic heart. Copyright© by Editorial Board of Journal of Sichuan University (Medical Science Edition).

Entities:  

Keywords:  Asprosin; CMECs; Diabetes; Oxidative stress; Spartin

Mesh:

Substances:

Year:  2019        PMID: 31880113

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  5 in total

Review 1.  Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease.

Authors:  Mehmet Akif Ovali; Ibrahim Bozgeyik
Journal:  Mol Syndromol       Date:  2022-02-08

Review 2.  A state of the art review on the novel mediator asprosin in the metabolic syndrome.

Authors:  Carla Luís; Rúben Fernandes; Raquel Soares; Pedro von Hafe
Journal:  Porto Biomed J       Date:  2020-12-10

3.  Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature.

Authors:  Agnieszka Irena Mazur-Bialy
Journal:  Nutrients       Date:  2021-02-14       Impact factor: 5.717

4.  Evaluation of Plasma Asprosin Concentration in Patients with Coronary Artery Disease.

Authors:  Cengiz Güven; Hüseyin Kafadar
Journal:  Braz J Cardiovasc Surg       Date:  2022-08-16

5.  Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease.

Authors:  Hao-Hua Wang; Wan-Ying Luo; Min Lin; Xiao-Jing Li; Guang-Da Xiang; Silvia D Triganti
Journal:  Physiol Res       Date:  2021-03-08       Impact factor: 1.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.